Data to establish the optimal standard regimen and predicting the response to docetaxel therapy
This paper contains data to establish the optimal standard regimen and predicting the response to docetaxel therapy (Moawad, 2014) [1]. Docetaxel has been in use for over a decade without demonstrating data indicates a predictable response in the treatment of cancer. Data of puzzling response to doc...
Main Author: | Emad Y. Moawad |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-12-01
|
Series: | Data in Brief |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340915002279 |
Similar Items
-
Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
by: Jie Xu, et al.
Published: (2018-10-01) -
Prediction of therapeutic response to paclitaxel, docetaxel and ixabepilone in breast cancer
by: Kadra, Gais
Published: (2011) -
Feasibility study of docetaxel, oxaliplatin and capecitabine combination regimen in advanced gastric or gastroesophageal adenocarcinoma
by: Gaurav Goel, et al.
Published: (2010-04-01) -
Results of combination treatment using docetaxel in an adjuvant chemotherapy regimen for resectable breast cancer
by: L. V. Bolotina, et al.
Published: (2014-07-01) -
S-1 plus docetaxel: a safe and effective chemotherapy regimen for stage III gastric cancer
by: Feiyu Diao, et al.
Published: (2019-10-01)